B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Ixazomib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Ixazomib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

epoxomycin
3 shared targets
lactacystin
2 shared targets
mg
3 shared targets
delanzomib
3 shared targets
carfilzomib
3 shared targets
Reserpine
3 shared targets · score 41.7
Emodin
2 shared targets · score 40.2
Bortezomib
3 shared targets · score 44.2
Loading evidence profile...

This evidence profile for Ixazomib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.